XORTX’s presentation will be recorded and available after the conference on the Company’s website. About XORTX Therapeutics Inc.
Then, on December 2, 2024, Applied Therapeutics disclosed it received a "warning letter" from the FDA referring to the clinical trial issues underlying the CRL. Applied Therapeutics' common stock fell ...
Clinical trial agreements (CTAs) form the foundation of any clinical research initiative, establishing the legal and ...